Two days after the Los Angeles Public Health Department announced that the much-talked-about UK variant of Covid-19, known as B.1.1.7, had been identified in the region, the California Department of Public Health revealed that another lesser-known strain had been circulating in the county as well.
Known as L452R, the newly announced arrival was first identified in Denmark in March. It showed up in California as early as May.
Dr. Charles Chiu, a virologist and professor of laboratory medicine at UCSF who, in concert with state authorities, has been genetically sequencing test samples to identify new variants said early indications are the L452R might be less susceptible to the currently approved vaccines, but more investigation is needed.
“This variant carries three mutations, including L452R, in the spike protein, which the virus uses to attach to and enter cells, and is the target of the two vaccines that are currently available in the United States,” said Dr. Chiu. A spike protein mutation could, then, interfere with the vaccine’s efficacy.
According to the California Department of Public Health, Santa Clara County has sequenced a large number of positive specimens collected from community testing sites and outbreaks in the county. The L452R was present in specimens from the community and from several large outbreaks, including outbreaks where very high numbers of people exposed contracted the virus.
“This variant was identified in several large outbreaks in our county,” said Santa Clara County Health Officer Dr. Sara Cody. She called that correlation “a red flag and must be investigated further.”
The new variant also has been detected in Los Angeles, Mono, Monterey, Orange, Riverside, San Francisco, San Bernardino, San Diego, San Luis Obispo, Humboldt and Lake counties. Because genomic sequencing is sparse, it is currently unknown how prevalent L452 is statewide, nationally or globally.
Dr. Chiu said L452R grew from about 3.8% of the samples he tested in late November 2020 through early December to more than 25.2% in late December through early January 2021.
And there might be another issue with vaccine efficacy.
California’s State Epidemiologist Dr. Erica Pan said on Sunday that a “higher than usual” number of people had apparent allergic reactions to a batch of Moderna’s vaccine at a San Diego-area clinic.
“Out of an extreme abundance of caution,” Pan recommended that clinics should stop using doses from that specific batch until it is investigated.
California received about 330,000 doses from the lot in question. That equates to approximately 10% of all vaccine distributed to date across the state.
On Monday, the state’s numbers were mostly down, which is good. There were just over 30,000 new cases, 201 new deaths, 20,968 virus patients hospitalized and 1,113 ICU beds available. That last figure is the lowest number of ICU beds available during the pandemic, which is worrying.
There is also the potentially more contagious UK variant, B.1.1.7., on the horizon. Los Angeles Public Health officials confirmed the first case of that strain in the area over the weekend.
Though Saturday may mark the strain’s first identified appearance in Los Angeles County, health officials said in recent weeks that it was very likely already circulating in L.A. B.1.1.7 had previously made its way through San Diego and San Bernardino Counties. Before that, the strain had been found in Colorado, where it made its U.S. landfall.
The CDC warned that the presence of B.1.1.7 may mark a new phase of “exponential growth” in total Covid-19 cases.
“Current projections by the experts predict that if left unchecked, this variant could dominate locally by March,” Los Angeles Public Health director Barbara Ferrer said on Friday.
We can now add to that the threat of a potentially vaccine-resistant strain, L452R, as well.
As a result, L.A. County officials have been discussing the possibility of new restrictions for the shutdown-weary county.
Must Read Stories
Subscribe to Deadline Breaking News Alerts and keep your inbox happy.